CHOSEN by Dermatology

Private

SILPHION RESEARCH PRIVATE LIMITED

Private

SILPHION RESEARCH PRIVATE LIMITED

2020

Founded in 2020, CHOSEN by Dermatology operates in Ecommerce industry. Initially focusing on providing scientifically formulated skin care solutions, the company has expanded its product line to inclu...

Funding stage:

Series A

Last funding:

03/05/2026

Total funding:

$6.30 Mn+

Revenue:

₹28.6 Cr+ (FY25)

Investors

Employee count:

Last 90d

Web traffic:

100.58K

Last 30d

CHOSEN by Dermatology: Financial Breakdown

Decoding financial health metrics of CHOSEN by Dermatology

Total Revenue
₹28.6 Cr
Total Expenses
₹33.4 Cr
Profit After Tax
₹-3.8 Cr
Total Assets
₹22.1 Cr
Net Profit Margin
-13.4%

Note: Above mentioned stats are for FY24-25

FAQs on Financials of CHOSEN by Dermatology

No. In FY25, CHOSEN by Dermatology reported a net loss of ₹3.8 Cr, so it was not profitable.

CHOSEN by Dermatology's estimated EBITDA for FY25 was ₹-2.9 Cr, derived from its profit before tax, finance costs, and depreciation & amortisation.

In FY25, CHOSEN by Dermatology posted revenue of ₹28.6 Cr and a net loss of ₹3.8 Cr. Explore the full financials of CHOSEN by Dermatology here...

Disclaimer

Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.

Quick Links

CHOSEN by Dermatology - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More

CHOSEN by Dermatology: Financial Breakdown

FAQs on Financials of CHOSEN by Dermatology

Is CHOSEN by Dermatology profitable?

What is CHOSEN by Dermatology's EBITDA?

How is CHOSEN by Dermatology's business performing?

Disclaimer